D-TACE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for D-TACE, covering 2022-10-17 to 2023-11-29. Get the full timeline:
Most recent: Clinical Trial Update: Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]